Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Condition(s):Atrophy, GeographicLast Updated:May 5, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Atrophy, GeographicLast Updated:May 5, 2017Completed
Condition(s):Eye Diseases; Macular Degeneration, Wet; Sub-Macular HemorrhageLast Updated:November 8, 2023Recruiting
Condition(s):Age-related Macular DegenerationLast Updated:March 19, 2015Completed
Condition(s):Age Related Macular DegenerationLast Updated:August 4, 2020Completed
Condition(s):Macular Degeneration, Dry; Primary Open-angle GlaucomaLast Updated:March 15, 2023Recruiting
Condition(s):Age-related Macular DegenerationLast Updated:May 30, 2013Completed
Condition(s):Inclusion CriteriaLast Updated:February 23, 2017Unknown status
Condition(s):Macular DegenerationLast Updated:December 12, 2016Completed
Condition(s):Age-related Macular DegenerationLast Updated:March 22, 2023Not yet recruiting
Condition(s):Choroidal Neovascularization (CNV); Age-related Macular Degeneration (AMD); Early MarkersLast Updated:November 10, 2010Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.